#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alternating hemiplegia of childhood Inflammatory myofibroblastic tumour Congenital myopathy Langerhans' cell histiocytosis Alagille syndrome Marginal zone lymphoma Cardiomyopathy Non-small cell lung cancer recurrent Nephropathy Glycogen storage disease type II Scleroderma associated digital ulcer Craniocerebral injury Familial dilated cardiomyopathy Congenital generalised lipodystrophy Oropharyngeal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Trials in Disease Familial amyotrophic lateral sclerosis – Treatment Soft tissue sarcoma Sarcoma – Treatment Erdheim-Chester disease – Life with Disease Prolymphocytic leukaemia Hereditary optic atrophy – Life with Disease Angelman’s syndrome – Life with Disease Toxic epidermal necrolysis Loeys-Dietz syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Niflumic Acid Clobetasol Eclitasertib Siremadlin Naproxen GSKVX000000039711 Benzalkonium Chloride A49 Dexchlorpheniramine Maleate Nifedipine Tipiracil Hydrochloride Mk-1942 AZD0516 Elacestrant Dihydrochloride ATIRMOCICLIB Pegvaliase Midostaurin Canakinumab Avutometinib Hydroxocobalamin More therapies…

    Learn about Your Condition

    Peritoneal neoplasm Catatonia Binge eating Acute respiratory failure Premature rupture of membranes Pulmonary vascular disorder Lichen planus Large cell lung cancer stage 0 Cytokine release syndrome Ovarian cancer recurrent Tinnitus Thromboembolectomy Primary biliary cholangitis Lower limb fracture Dent's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the safety of dazodalibep in patients with Sjögren’s Syndrome over a long period of time

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6

  • Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer metastatic
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Atezolizumab
    • BNT327
    • Carboplatin
    France Germany Italy The Netherlands Poland Romania +1

  • A study testing etentamig alone or with drug combinations in adult patients with multiple myeloma to assess safety and changes in disease activity

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Carfilzomib
    • Daratumumab
    • Dexamethasone
    Norway

  • A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

    Recruiting

    2 1
    Czechia France Germany Italy Poland Portugal +1

  • Study of ECI830, ribociclib, and fulvestrant in patients with advanced hormone receptor positive, HER2-negative breast cancer and advanced solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Neoplasm malignant
    Investigated Drugs:
    • Goserelin
    • Ribociclib
    • Leuprorelin Acetate
    Czechia Denmark France Germany Italy Spain

  • A study comparing furazidin and clindamycin for women with bacterial vaginosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clindamycin Phosphate
    Czechia Italy Poland Slovakia
Previous Page
1 … 67 68 69 70 71 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!